Subject: I'm sorry

I'm sorry! I sent out an offer earlier today that was confusing, so here is a quick clarification.

For the next 48 hours, when you claim the “CAR-T Funding Brief” for $49 at this link, you will also get the “Global CAR-T Industry Database 2018” for free ($49 value).

Both products will be immediately available for download. Claim this two-for-one offer here: 



Be Great, 
Cade


p.s. Any further questions? Hit reply to this email.

p.p.s. You can see the original email below.




Yesterday, CAR-T developer Autolus announced a $150 million dollar IPO.

Following IPOs by CAR-T players Kite Pharma, Bellicum Pharmaceuticals, Juno Therapeutics, and Cellectis totaling over $750 million, the momentum appears to be accelerating. 

The Autolus contribution brings the total value of CAR-T IPOs to nearly $1 BILLION.

Would you benefit from knowing all CAR-T investments worldwide, including IPOs, financing rounds, acquisitions, partnerships and asset agreements?

For the next 48 hours, you can claim these market insights for only $49 and get the "Global CAR-T Industry Database 2018" for FREE.  




Be Great,
Cade
BIOINFORMANT | 800 Corporate Drive, Suite 301, Stafford, VA 22554, United States
You may unsubscribe or change your contact details at any time.

    This is an online snapshot of a newsletter created by the owner of BioInformant Worldwide, LLC | Stem Cell Industry Data (BioInformant.com, BIOINFORMANT | 800 Corporate Drive, Suite 301, 22554 Stafford) and sent via GetResponse on 2018-06-27. Report abuse